Your session is about to expire
← Back to Search
Other
Meal Replacement and Lifestyle Modification for Obesity (ADMIRE Trial)
N/A
Recruiting
Led By Justin Ryder, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Tanner stage 2, 3, or 4
11 to less than 16 years old
Must not have
Individuals with a diagnosed eating disorder of anorexia nervosa, bulimia or binge eating disorder
Type 1 or 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 17 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will investigate why people who lose weight often regain it and whether hormones play a role. Participants will drink shakes & eat calorie-controlled frozen meals for 10 weeks, & have 13 visits over 35 weeks. Fruits & vegetables provided by participants.
Who is the study for?
This trial is for young individuals aged 11 to less than 16 with severe obesity, measured by a BMI >30 kg/m^2 or above the 95th percentile. They should be in the middle stages of puberty (Tanner stage 2-4). Those who are pregnant, have had bariatric surgery, use certain weight-loss drugs, have specific health conditions like polycystic ovary syndrome or thyroid issues, cancer within the last decade, hormonal treatments, genetic obesity forms or diagnosed eating disorders can't participate.
What is being tested?
The study tests if meal replacements and lifestyle changes affect why youth regain weight after dieting. Participants will replace two meals with shakes and eat a calorie-controlled dinner for a period followed by observation. The goal is to understand hormone roles in weight regain post-dieting.
What are the potential side effects?
Potential side effects may include digestive discomfort from dietary changes and possible nutritional imbalances due to altered eating patterns during the meal replacement phase.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My body is in the middle stages of puberty.
Select...
I am between 11 and 15 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with an eating disorder such as anorexia, bulimia, or binge eating.
Select...
I have diabetes.
Select...
I am currently taking supplemental hormones.
Select...
My physical development is at the earliest or latest stage according to Tanner stages.
Select...
I have had weight loss surgery in the past.
Select...
I have a genetic form of obesity or obesity caused by brain signals.
Select...
I am currently receiving growth hormone treatment.
Select...
I have had cancer within the last 10 years.
Select...
I have been diagnosed with polycystic ovary syndrome.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 17 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~17 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in fat mass regain after initial weight loss with meal replacement therapy (MRT)
Change in gastric inhibitory polypeptide
Change in ghrelin
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Meal Replacement and Lifestyle TherapyExperimental Treatment1 Intervention
Participants in this study will have an 8-week meal replacement therapy period in which they are asked to reduce their BMI by 5% by following a prescribed eating regimen consisting of meal replacement shakes and/or frozen meals for breakfast and lunch. For dinner they will consume a pre-packaged frozen entree to be consumed with two servings of fruit and three servings of vegetables per day. Participants will also have lifestyle/behavioral modification counseling every 2 weeks throughout the entire study.
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,439 Previous Clinical Trials
1,621,698 Total Patients Enrolled
Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
273 Previous Clinical Trials
5,183,291 Total Patients Enrolled
Justin Ryder, PhDPrincipal InvestigatorAnn & Robert H Lurie Children's Hospital of Chicago
2 Previous Clinical Trials
80 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with an eating disorder such as anorexia, bulimia, or binge eating.I have diabetes.I have used weight loss medication in the last 3 months.I am currently taking supplemental hormones.My physical development is at the earliest or latest stage according to Tanner stages.I have had weight loss surgery in the past.My body is in the middle stages of puberty.I have a genetic form of obesity or obesity caused by brain signals.I am currently receiving growth hormone treatment.I have a thyroid condition.I have had cancer within the last 10 years.I have been diagnosed with polycystic ovary syndrome.I am between 11 and 15 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Meal Replacement and Lifestyle Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.